
Kinarus Therapeutics Holding AG
SIX:KNRS

Fundamental Analysis


Revenue & Expenses Breakdown
Kinarus Therapeutics Holding AG
Balance Sheet Decomposition
Kinarus Therapeutics Holding AG
Current Assets | 111k |
Receivables | 108k |
Other Current Assets | 3k |
Free Cash Flow Analysis
Kinarus Therapeutics Holding AG
CHF | |
Free Cash Flow | CHF |
Earnings Waterfall
Kinarus Therapeutics Holding AG
Revenue
|
0
CHF
|
Operating Expenses
|
-13.9m
CHF
|
Operating Income
|
-13.9m
CHF
|
Other Expenses
|
-6k
CHF
|
Net Income
|
-13.9m
CHF
|
KNRS Profitability Score
Profitability Due Diligence
Kinarus Therapeutics Holding AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Kinarus Therapeutics Holding AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.
KNRS Solvency Score
Solvency Due Diligence
Kinarus Therapeutics Holding AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Kinarus Therapeutics Holding AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
KNRS Price Targets Summary
Kinarus Therapeutics Holding AG
Dividends
Current shareholder yield for KNRS is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?